Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...

Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

House Republicans’ funding patch includes cutting funds for the Congressionally Directed Medical Research Programs, an agency ...

OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil.

The most recent trading session ended with Merck (MRK) standing at $93.43, reflecting a -1.37% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily ...

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...